Full name
DYSTROGEN GENE THERAPIES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
DYSTROGEN GENE THERAPIES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. WŁADYSŁAWA PYTLASIŃSKIEGO 10/12 / 14, 00-777 WARSZAWA
TAX ID5213873826
Rate company:
DYSTROGEN GENE THERAPIES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5213873826
KRS0000799476
Share capital5,000.00 zł
address
UL. WŁADYSŁAWA PYTLASIŃSKIEGO 10/12 / 14, 00-777 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5213873826
REGON
384124530
KRS
0000799476
Legal form
limited liability company
Register Address
UL. WŁADYSŁAWA PYTLASIŃSKIEGO 10/12 / 14, 00-777 WARSZAWA
Date of registration in KRS
2019-08-14
Date of commencement of economic activity
2019-08-14
Act signature
RDF/574628/23/27
Pkd codes
72.11.Z - Research and experimental development on biotechnology
21.20.Z - Manufacture of medicines and other pharmaceutical products
62.02.Z - Computer consultancy activities
70.22.Z - Business and other management consultancy activities
71.12.Z - Engineering activities and related technical consultancy
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2020 | 2021 | ||
|---|---|---|---|
K PLN | K PLN | % | |
Assets  | 122,4 | 105,9 | -13,5 |
Gross profit (loss) | 36,2 | 8,8 | -75,6 |
Net profit (loss) | 32,8 | 7,9 | -76 |
Liabilities and provisions for liabilities | 84,5 | 60,2 | -28,8 |
Income tax | 3,3 | 0,9 | -71,9 |
Working assets | 117,4 | 100,9 | -14 |
Equity capital | 37,8 | 45,7 | 20,8 |
Basic operational activity income | 518,6 | 126,4 | -75,6 |
% | % | p.p. | |
Profitability of capital | 86,8 | 17,2 | -69,6 |
Equity capital to total assets | 30,9 | 43,2 | 12,3 |
Gross profit margin | 7 | 7 | 0 |
Financial statements
01-01-2021 - 31-12-2021
Annual financial report
Download xml01-01-2021 - 31-12-2021
Annual financial report
Download pdf01-01-2021 - 31-12-2021
Resolution or decision approving the annual financial statements
Download pdfuses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
BioCraft Paweł Olszewski
Chwaszczyno
India Gold sp. z o.o.
Warszawa